In-vitro pharmacology safety assessment of three compounds

Ended Purchase Order Awarded

Contract number
75N95020P00664
Awardee
Awarding agency
Obligated
$21,224

Award facts

Opportunity
  • 75N95020Q00321 Solicitation number
Contract value 100% obligated
$21,224.46 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
NAICS code
541380 Testing Laboratories and Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Taiwan

Award details come from SAM.gov/FPDS.

Quick answers

Who was awarded contract 75N95020P00664?

75N95020P00664 was awarded to Eurofins Panlabs Discovery Services Taiwan, LTD. by National Institute on Drug Abuse (National Institutes of Health) on September 18, 2020.

How much is contract 75N95020P00664 worth?

The government has obligated $21,224 on 75N95020P00664.

Which agency awarded contract 75N95020P00664?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020P00664, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Was contract 75N95020P00664 competed?

The extent of competition for 75N95020P00664 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award